Understanding Human Microbiota Offers Novel and Promising Therapeutic Options against <i>Candida</i> Infections
Human fungal pathogens particularly of <i>Candida</i> species are one of the major causes of hospital acquired infections in immunocompromised patients. The limited arsenal of antifungal drugs to treat <i>Candida</i> infections with concomitant evolution of multidrug resistan...
Main Authors: | Saif Hameed, Sandeep Hans, Ross Monasky, Shankar Thangamani, Zeeshan Fatima |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Pathogens |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-0817/10/2/183 |
Similar Items
-
Revisiting the Vital Drivers and Mechanisms of β-Glucan Masking in Human Fungal Pathogen, <i>Candida albicans</i>
by: Saif Hameed, et al.
Published: (2021-07-01) -
Promising Drug Candidates and New Strategies for Fighting against the Emerging Superbug <i>Candida auris</i>
by: Muriel Billamboz, et al.
Published: (2021-03-01) -
Pathogenesis and Virulence of <i>Candida albicans</i> and <i>Candida glabrata</i>
by: Mariana Henriques, et al.
Published: (2020-09-01) -
Overview on the Infections Related to Rare <i>Candida</i> Species
by: Sunil Kumar, et al.
Published: (2022-08-01) -
Marine Compounds with Anti-<i>Candida</i> sp. Activity: A Promised “Land” for New Antifungals
by: Anelise Maria Costa Vasconcelos Alves, et al.
Published: (2022-06-01)